<sentence id="0">Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells .</sentence>
<sentence id="1">Acquired immunodeficiency syndrome ( AIDS ) results from infection with a human immunodeficiency virus ( HIV ) .</sentence>
<sentence id="2">The long terminal repeat ( LTR ) region of HIV proviral DNA contains binding sites for nuclear factor kappa B ( NF-kappa B ) , and <scope type="spec" id="0"> this transcriptional activator <cue type="spec" id="0">appears</cue> to regulate HIV activation</scope> .</sentence>
<sentence id="3">Recent findings <scope type="spec" id="1"> <cue type="spec" id="1">suggest</cue> an involvement of reactive oxygen species ( ROS ) in signal transduction pathways leading to NF-kappa B activation</scope> .</sentence>
<sentence id="4">The present study was based on reports that antioxidants which eliminate ROS <scope type="spec" id="2"> <cue type="spec" id="2">should</cue> block the activation of NF-kappa B and subsequently HIV transcription</scope> , and thus <scope type="spec" id="3"> antioxidants <cue type="spec" id="3">can</cue> be used as therapeutic agents for AIDS</scope> .</sentence>
<sentence id="5">Incubation of Jurkat T cells ( 1 x 10(6) cells/ml ) with a natural thiol antioxidant , alpha-lipoic acid , prior to the stimulation of cells was found to inhibit NF-kappa B activation induced by tumor necrosis factor-alpha ( 25 ng/ml ) or by phorbol 12-myristate 13-acetate ( 50 ng/ml ) .</sentence>
<sentence id="6">The inhibitory action of alpha-lipoic acid was found to be very potent as only 4 mM was needed for a complete inhibition , whereas 20 mM was required for N-acetylcysteine .</sentence>
<sentence id="7">These results <scope type="spec" id="4"> <cue type="spec" id="4">indicate that</cue> alpha-lipoic acid <scope type="spec" id="5"> <cue type="spec" id="5">may</cue> be effective in AIDS therapeutics</scope></scope> .</sentence>